https://www.selleckchem.com/pr....oducts/fluspirilene.
The authors posit the need for rapid evaluation of therapies for COVID-19 as an inflection point spurring a much-needed rethinking of our research enterprise.Background Bone mineral density at the humeral head is reduced in patients with chronic rotator cuff tears. Bone loss in the humeral head is associated with repair failure after rotator cuff reconstruction. Bisphosphonates (eg, zoledronic acid) increase bone mineral density. Hypothesis Zoledronic acid improves bone mineral density of the humeral head and biomechanical properti
Like
Comment
Share
